Suppr超能文献

[血浆中激肽生成的估计方法]

[Method of estimating kininogenesis in blood plasma].

作者信息

Surovikina M S, Lapshina I M, Maslikova G V, Drozdova G A, Vasil'ev A N

出版信息

Biull Eksp Biol Med. 1983 May;95(5):115-8.

PMID:6552201
Abstract

It is suggested that the kininogenesis should be assessed from 3 forms of kallikrein which are detected on the basis of their kininogenase activity in whole blood plasma. Heating of blood plasma acidified to pH 3.0 for 15-20 min at 61 degrees C allows for the conditions under which the kallikrein inhibitors (alpha 1-antitrypsin, alpha 2-macroglobulin) are destroyed whereas kallikrein, prekallikrein, low- and high-molecular kininogens (HMK) are preserved, thus constituting a complex of proteins making the kininogenase reaction feasible. Addition of purified preparations of HMK to the neutralized samples of normal and sick individuals' plasma permitted the demonstration that as the kallikrein is raised, the kininogenesis gets actually activated, during which the blood manifests, in the presence of kallikrein hyperactivity, a sufficient amount of HMK. Provided the kallikrein content drops by 50%, the kininogenesis is reduced, which is accounted for by depletion of blood HMK. A 70%- and a greater decrease in the kallikrein content attests to the kininogenesis reduction because of the diminished levels of HMK, prekallikrein and kallikrein. The regularities described have been confirmed by the agreement between the blood plasma kallikrein level and the concentration of blood free kinins revealed during examination of 68 normal individuals and 231 patients suffering from different inflammatory-allergic diseases of the respiratory and hepatobiliary organs, and from diabetes mellitus.

摘要

建议应从3种激肽释放酶形式来评估激肽生成,这3种激肽释放酶是根据它们在全血血浆中的激肽原酶活性检测出来的。将酸化至pH 3.0的血浆在61℃加热15 - 20分钟,可创造出这样的条件:激肽释放酶抑制剂(α1 - 抗胰蛋白酶、α2 - 巨球蛋白)被破坏,而激肽释放酶、前激肽释放酶、低分子和高分子激肽原(HMK)得以保留,从而构成一个使激肽原酶反应可行的蛋白质复合物。向正常人和病人血浆的中和样本中添加纯化的HMK制剂,可以证明随着激肽释放酶水平升高,激肽生成实际上被激活,在此过程中,在激肽释放酶活性亢进的情况下,血液中表现出足够量的HMK。如果激肽释放酶含量下降50%,激肽生成减少,这是由于血液中HMK耗竭所致。激肽释放酶含量下降70%及更多,则证明由于HMK、前激肽释放酶和激肽释放酶水平降低,激肽生成减少。在对68名正常人和231名患有呼吸和肝胆器官不同炎症 - 过敏性疾病以及糖尿病的患者进行检查期间,血浆激肽释放酶水平与血液中游离激肽浓度之间的一致性证实了上述规律。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验